Evidence map›Paper›PMID 30806959›Full record

ReviewAmerican journal of clinical dermatology2019

HIV-Related Skin Disease in the Era of Antiretroviral Therapy: Recognition and Management.

Khatiya Chelidze, Cristina Thomas, Aileen Yenting Chang, Esther Ellen Freeman

Abstract readReview
In one paragraph

Review in American journal of clinical dermatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Case Report: Role of Point-of-Care Ultrasound in the Diagnosis of Bacillary Angiomatosis.The American journal of tropical medicine and hygiene · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Khatiya ChelidzeWeill Cornell Medical College, Massachusetts General Hospital, 1300 York Avenue, New York, NY, 10021, USA.
Cristina ThomasDepartment of Dermatology, Massachusetts General Hospital, Harvard Medical School, Bartlett Hall 6R, Boston, MA, 02114, USA.
Aileen Yenting ChangDepartment of Dermatology, University of California, San Francisco, 505 Paranassus Avenue, San Francisco, CA, 94143, USA.
Esther Ellen FreemanDepartment of Dermatology, Massachusetts General Hospital, Harvard Medical School, Bartlett Hall 6R, Boston, MA, 02114, USA. efreeman@mgh.harvard.edu.

Funding

Improving the Care Cascade for HIV-associated Kaposi's Sarcoma in sub-Saharan AfricaK23AI136579 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI FREEMAN, ESTHER E · 2018 to 2022
$1.1M
Dermatology Foundation Career Development AwardNational Institute of Allergy and Infectious Diseases AI136579NIAID NIH HHS K23 AI136579
6 · The paper itself

Abstract

Antiretroviral therapy (ART) has revolutionized the treatment and prognosis of people living with HIV (PLHIV). With increased survival and improved overall health, PLHIV are experiencing dermatologic issues both specific to HIV and common to the general population. In this new era of ART, it is crucial for dermatologists to have a strong understanding of the broad range of cutaneous disease and treatment options in this unique population. In this review, we outline the most common skin diseases in PLHIV, including HIV-associated malignancies, inflammatory conditions, and infections, and focus on the role of ART in altering epidemiology, clinical features, diagnosis, and treatment of cutaneous conditions.

Indexed as

Anti-HIV AgentsClinical Trials as TopicDermatologic AgentsDiagnosis, DifferentialHIV InfectionsHumansSkin DiseasesTreatment OutcomeAnti-HIV AgentsDermatologic Agents

Identifiers

PMID30806959
PMCPMC6581453

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.